FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074054914> ?p ?o ?g. }

• W2074054914 endingPage "1658" @default.
• W2074054914 startingPage "1651" @default.
• W2074054914 abstract "Angiopoietin-like protein 2 (ANGPTL2) plays an important role in inflammatory carcinogenesis and tumor metastasis. The compound GDC-0152 is a peptidomimetic small molecule antagonist of inhibitor of apoptosis (IAP) proteins with antitumor activity. However, the interaction between ANGPTL2 and GDC-0152 has not been studied. It has been proven that ANGPTL2 promotes metastasis of osteosarcoma. Therefore, in the present study, the effect of GDC-0152 on the malignant progression of osteosarcoma promoted by ANGPTL2 was investigated. Human osteosarcoma cell line SaOS2 cells were pre-treated or non-treated with GDC-0152 and then exposed to recombinant human ANGPTL2. The viability of SaOS2 cells was determined by MTT assay, the migration of SaOS2 cells was analyzed by chamber migration assay kit, and the SaOS2 cell apoptosis was determined by fluorescence-activated cell sorting (FACS) and nuclear staining. Treatment with ANGPTL2 increased SaOS2 cell growth and migration and decreased cell apoptosis. The increased cell growth and decreased cell apoptosis were significantly attenuated in SaOS2 cells receiving GDC-0152. However, the ANGPTL2-increased SaOS2 cell migration was not inhibited by GDC-0152 treatment. Furthermore, western blot analysis showed that the activation of phosphatidyl inositol 3-kinase (PI3K) (p85), PI3K (p110), protein kinase B (Akt) (Ser473), Akt (Thr308) and p38 mitogen-activated protein kinase (p38MAPK) were upregulated by ANGPTL2. Quantitative real-time polymerase chain reaction (qTR-PCR) and gelatin zymography showed that the mRNA expression and activity of matrix metalloproteinase-9 (MMP-9) and matrix metalloproteinase-2 (MMP-2) were also increased by ANGPTL2. The upregulated activation of PI3K and Akt were significantly suppressed by the treatment of GDC-0152. In contrast, GDC-0152 did not suppress ANGPTL2-induced p38MAPK phosphorylation, MMP-9/MMP-2 mRNA expression or MMP-9/MMP-2 activity. Taken together, these data indicate that GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway. The present study indicated a novel therapeutic strategy to inhibit tumor growth by indirectly preventing ANGPTL2 signaling." @default.
• W2074054914 created "2016-06-24" @default.
• W2074054914 creator A5010369413 @default.
• W2074054914 creator A5027138510 @default.
• W2074054914 creator A5030362253 @default.
• W2074054914 creator A5041587003 @default.
• W2074054914 creator A5051771989 @default.
• W2074054914 creator A5054303514 @default.
• W2074054914 creator A5055861690 @default.
• W2074054914 creator A5072166088 @default.
• W2074054914 date "2015-02-04" @default.
• W2074054914 modified "2023-09-29" @default.
• W2074054914 title "GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway" @default.
• W2074054914 cites W1966897529 @default.
• W2074054914 cites W1998918148 @default.
• W2074054914 cites W2001515311 @default.
• W2074054914 cites W2003481405 @default.
• W2074054914 cites W2005334224 @default.
• W2074054914 cites W2018906703 @default.
• W2074054914 cites W2025522492 @default.
• W2074054914 cites W2049181801 @default.
• W2074054914 cites W2065376152 @default.
• W2074054914 cites W2070732456 @default.
• W2074054914 cites W2076633056 @default.
• W2074054914 cites W2081455569 @default.
• W2074054914 cites W2091767953 @default.
• W2074054914 cites W2094352498 @default.
• W2074054914 cites W2100837269 @default.
• W2074054914 cites W2102403951 @default.
• W2074054914 cites W2102564037 @default.
• W2074054914 cites W2108994302 @default.
• W2074054914 cites W2113668317 @default.
• W2074054914 cites W2118821808 @default.
• W2074054914 cites W2132237956 @default.
• W2074054914 cites W2145506613 @default.
• W2074054914 cites W2161065243 @default.
• W2074054914 cites W2169912377 @default.
• W2074054914 cites W2170541481 @default.
• W2074054914 cites W2170934220 @default.
• W2074054914 cites W2388163742 @default.
• W2074054914 cites W4239357337 @default.
• W2074054914 cites W49857904 @default.
• W2074054914 doi "https://doi.org/10.3892/ijo.2015.2872" @default.
• W2074054914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25651778" @default.
• W2074054914 hasPublicationYear "2015" @default.
• W2074054914 type Work @default.
• W2074054914 sameAs 2074054914 @default.
• W2074054914 citedByCount "26" @default.
• W2074054914 countsByYear W20740549142015 @default.
• W2074054914 countsByYear W20740549142016 @default.
• W2074054914 countsByYear W20740549142017 @default.
• W2074054914 countsByYear W20740549142018 @default.
• W2074054914 countsByYear W20740549142019 @default.
• W2074054914 countsByYear W20740549142020 @default.
• W2074054914 countsByYear W20740549142021 @default.
• W2074054914 countsByYear W20740549142022 @default.
• W2074054914 crossrefType "journal-article" @default.
• W2074054914 hasAuthorship W2074054914A5010369413 @default.
• W2074054914 hasAuthorship W2074054914A5027138510 @default.
• W2074054914 hasAuthorship W2074054914A5030362253 @default.
• W2074054914 hasAuthorship W2074054914A5041587003 @default.
• W2074054914 hasAuthorship W2074054914A5051771989 @default.
• W2074054914 hasAuthorship W2074054914A5054303514 @default.
• W2074054914 hasAuthorship W2074054914A5055861690 @default.
• W2074054914 hasAuthorship W2074054914A5072166088 @default.
• W2074054914 hasBestOaLocation W20740549141 @default.
• W2074054914 hasConcept C109523444 @default.
• W2074054914 hasConcept C153911025 @default.
• W2074054914 hasConcept C185592680 @default.
• W2074054914 hasConcept C190283241 @default.
• W2074054914 hasConcept C29537977 @default.
• W2074054914 hasConcept C502942594 @default.
• W2074054914 hasConcept C55493867 @default.
• W2074054914 hasConcept C62112901 @default.
• W2074054914 hasConcept C75217442 @default.
• W2074054914 hasConcept C86554907 @default.
• W2074054914 hasConcept C86803240 @default.
• W2074054914 hasConceptScore W2074054914C109523444 @default.
• W2074054914 hasConceptScore W2074054914C153911025 @default.
• W2074054914 hasConceptScore W2074054914C185592680 @default.
• W2074054914 hasConceptScore W2074054914C190283241 @default.
• W2074054914 hasConceptScore W2074054914C29537977 @default.
• W2074054914 hasConceptScore W2074054914C502942594 @default.
• W2074054914 hasConceptScore W2074054914C55493867 @default.
• W2074054914 hasConceptScore W2074054914C62112901 @default.
• W2074054914 hasConceptScore W2074054914C75217442 @default.
• W2074054914 hasConceptScore W2074054914C86554907 @default.
• W2074054914 hasConceptScore W2074054914C86803240 @default.
• W2074054914 hasIssue "4" @default.
• W2074054914 hasLocation W20740549141 @default.
• W2074054914 hasLocation W20740549142 @default.
• W2074054914 hasOpenAccess W2074054914 @default.
• W2074054914 hasPrimaryLocation W20740549141 @default.
• W2074054914 hasRelatedWork W1988747615 @default.
• W2074054914 hasRelatedWork W2278983970 @default.
• W2074054914 hasRelatedWork W2362061149 @default.
• W2074054914 hasRelatedWork W2382230817 @default.
• W2074054914 hasRelatedWork W2394129978 @default.

• next